Verrica Pharmaceuticals Inc. Depreciation in USD from 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Verrica Pharmaceuticals Inc. quarterly/annual Depreciation history and growth rate from 2018 to Q3 2025.
  • Verrica Pharmaceuticals Inc. Depreciation for the quarter ending September 30, 2025 was $21.8K, a 78.2% decline year-over-year.
  • Verrica Pharmaceuticals Inc. Depreciation for the twelve months ending September 30, 2025 was $135K, a 74.3% decline year-over-year.
  • Verrica Pharmaceuticals Inc. annual Depreciation for 2024 was $342K, a 35.5% decline from 2023.
  • Verrica Pharmaceuticals Inc. annual Depreciation for 2023 was $530K, a 16.7% increase from 2022.
  • Verrica Pharmaceuticals Inc. annual Depreciation for 2022 was $454K, a 86.1% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)

Verrica Pharmaceuticals Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $135K $21.8K -$78.2K -78.2% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-14
Q2 2025 $213K $45K -$55K -55% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-12
Q1 2025 $268K $52K -$74K -58.7% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q4 2024 $342K $16K -$183K -92% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-11
Q3 2024 $525K $100K $0 0% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-14
Q2 2024 $525K $100K $0 0% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-12
Q1 2024 $525K $126K -$5K -3.82% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13
Q4 2023 $530K $199K Oct 1, 2023 Dec 31, 2023 10-K 2025-03-11
Q3 2023 $100K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 $100K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $131K +$33K +33.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q1 2022 $98K +$87K +791% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 $11K -$3K -21.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q1 2020 $14K +$3K +27.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q1 2019 $11K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07

Verrica Pharmaceuticals Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $342K -$188K -35.5% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-11
2023 $530K +$76K +16.7% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-11
2022 $454K +$210K +86.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $244K +$201K +467% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-06
2020 $43K -$21.2K -33% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-02
2019 $64.2K +$43.9K +216% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-17
2018 $20.3K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.